PL2900216T3 - Stabilizowane wodne kompozycje środków blokujących przewodnictwo nerwowo-mięśniowe - Google Patents

Stabilizowane wodne kompozycje środków blokujących przewodnictwo nerwowo-mięśniowe

Info

Publication number
PL2900216T3
PL2900216T3 PL13766501T PL13766501T PL2900216T3 PL 2900216 T3 PL2900216 T3 PL 2900216T3 PL 13766501 T PL13766501 T PL 13766501T PL 13766501 T PL13766501 T PL 13766501T PL 2900216 T3 PL2900216 T3 PL 2900216T3
Authority
PL
Poland
Prior art keywords
blocking agents
aqueous compositions
stabilized aqueous
neuromuscular blocking
neuromuscular
Prior art date
Application number
PL13766501T
Other languages
English (en)
Inventor
Béjar Juan GIL
Ramia Cristina Timoneda
Original Assignee
Braun Melsungen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braun Melsungen Ag filed Critical Braun Melsungen Ag
Publication of PL2900216T3 publication Critical patent/PL2900216T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL13766501T 2012-09-27 2013-09-19 Stabilizowane wodne kompozycje środków blokujących przewodnictwo nerwowo-mięśniowe PL2900216T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12186393.0A EP2712611A1 (en) 2012-09-27 2012-09-27 Stabilized aqueous compositions of neuromuscular blocking agents
EP13766501.4A EP2900216B1 (en) 2012-09-27 2013-09-19 Stabilized aqueous compositions of neuromuscular blocking agents
PCT/EP2013/069507 WO2014048836A1 (en) 2012-09-27 2013-09-19 Stabilized aqueous compositions of neuromuscular blocking agents

Publications (1)

Publication Number Publication Date
PL2900216T3 true PL2900216T3 (pl) 2017-10-31

Family

ID=47046351

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13766501T PL2900216T3 (pl) 2012-09-27 2013-09-19 Stabilizowane wodne kompozycje środków blokujących przewodnictwo nerwowo-mięśniowe

Country Status (19)

Country Link
US (2) US20150216979A1 (pl)
EP (2) EP2712611A1 (pl)
JP (1) JP6347784B2 (pl)
KR (1) KR102138392B1 (pl)
CN (1) CN104519872B (pl)
AU (1) AU2013322897B2 (pl)
BR (1) BR112015000688B1 (pl)
CA (1) CA2878714C (pl)
CY (1) CY1119086T1 (pl)
ES (1) ES2628076T3 (pl)
IL (1) IL236042A (pl)
MX (1) MX356212B (pl)
PL (1) PL2900216T3 (pl)
PT (1) PT2900216T (pl)
RS (1) RS56060B1 (pl)
RU (1) RU2695226C2 (pl)
TW (1) TWI595876B (pl)
WO (1) WO2014048836A1 (pl)
ZA (1) ZA201408945B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016016148A (es) * 2014-06-26 2017-04-25 Maruishi Pharma Preparacion de rocuronio con estabilidad mejorada.
JP2016121073A (ja) * 2014-12-24 2016-07-07 ニプロ株式会社 注射剤用医薬組成物の製造方法
WO2022078483A1 (zh) * 2020-10-15 2022-04-21 江苏恩华络康药物研发有限公司 甾体季铵化合物及其制备方法、制剂和用途
US20230014293A1 (en) * 2021-07-02 2023-01-19 Fresenius Kabi Austria Gmbh Aqueous, room-temperature stable rocuronium composition
EP4371553A1 (en) * 2022-11-16 2024-05-22 B. Braun Melsungen AG Composition comprising rocuronium

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681863B1 (fr) 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
IT1271031B (it) 1994-10-21 1997-05-26 Poli Ind Chimica Spa Composizioni farmaceutiche miorilassanti
WO2000044334A2 (en) * 1999-01-28 2000-08-03 Dinesh Shantilal Patel Novel injectable muscle relaxant formulations
US20060229258A1 (en) * 2003-07-30 2006-10-12 Daniela Serikaku Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
DE10337710A1 (de) * 2003-08-16 2005-03-10 Supramol Parenteral Colloids Amiodaron enthaltende Infusions- und Injektionslösungen
MY141763A (en) * 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates
US20060148841A1 (en) * 2004-02-26 2006-07-06 Lundeen James E Pharmaceutical composition comprising combination of non-alkaloid and alkaloid-based component for treating skeletal muscle spasm
US20060275331A1 (en) * 2004-08-31 2006-12-07 Borek Zaludek Pharmaceutical composition, method of manufacturing and therapeutic use thereof
EP1874319A2 (en) 2005-04-15 2008-01-09 Lyotropic Therapeutics, Inc. Formulations of quaternary ammonium neuromuscular blocking agents
CN1864667B (zh) * 2006-06-02 2010-10-06 重庆医药工业研究院有限责任公司 一种稳定的罗库溴铵冻干制剂及其制备方法
KR101403105B1 (ko) 2006-10-31 2014-06-09 엘지전자 주식회사 귀환 데이터 전송 방법, 귀환 데이터 생성 방법 및 데이터스케줄링 방법
WO2008065142A1 (en) 2006-11-29 2008-06-05 N.V. Organon Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative
CZ300664B6 (cs) * 2007-01-22 2009-07-15 Pliva-Lachema A. S. Sterilní kapalná farmaceutická kompozice a zpusob její výroby
KR20090102844A (ko) * 2007-01-22 2009-09-30 플리바-라케마 에이. 에스. 알콜 당-계 완충액을 함유한 옥살리플라틴 약제학적 조성물
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
US20100082749A1 (en) 2008-09-26 2010-04-01 Yahoo! Inc Retrospective spam filtering
CN101653412B (zh) * 2009-09-15 2014-06-25 尹双保 一种稳定的罗库溴铵注射液
AU2010339689B2 (en) 2010-01-07 2015-02-19 Alkermes Pharma Ireland Limited Quaternary ammonium salt prodrugs
EP2462913A1 (en) * 2010-12-10 2012-06-13 Fresenius Medical Care Deutschland GmbH Insert and vial for the infusion of liquids

Also Published As

Publication number Publication date
IL236042A0 (en) 2015-01-29
AU2013322897B2 (en) 2017-07-27
RU2695226C2 (ru) 2019-07-22
ES2628076T3 (es) 2017-08-01
IL236042A (en) 2017-06-29
KR20150058259A (ko) 2015-05-28
MX356212B (es) 2018-05-18
KR102138392B1 (ko) 2020-07-28
US20150216979A1 (en) 2015-08-06
WO2014048836A1 (en) 2014-04-03
CA2878714C (en) 2021-04-27
BR112015000688A2 (pt) 2017-06-27
US20200000925A1 (en) 2020-01-02
CA2878714A1 (en) 2014-04-03
PT2900216T (pt) 2017-06-23
RS56060B1 (sr) 2017-10-31
CN104519872B (zh) 2017-12-01
JP6347784B2 (ja) 2018-06-27
EP2900216B1 (en) 2017-04-26
AU2013322897A1 (en) 2015-01-29
ZA201408945B (en) 2015-11-25
CY1119086T1 (el) 2018-01-10
HK1205694A1 (en) 2015-12-24
JP2015531359A (ja) 2015-11-02
CN104519872A (zh) 2015-04-15
EP2712611A1 (en) 2014-04-02
RU2015115430A (ru) 2016-11-20
MX2015004056A (es) 2015-07-06
TW201412317A (zh) 2014-04-01
EP2900216A1 (en) 2015-08-05
US11998605B2 (en) 2024-06-04
BR112015000688B1 (pt) 2022-02-15
TWI595876B (zh) 2017-08-21

Similar Documents

Publication Publication Date Title
SG11201404577XA (en) Bactericidal agent composition
ZA201501709B (en) Cosmetic biphotonic compositions
PL2911506T3 (pl) Kompozycje zmniejszające dryf
PL2855579T3 (pl) Wodne kompozycje środka wiążącego
PT2648520T (pt) Formulação de pré-mistura de dexmedetomidina
ZA201602447B (en) Improved pharmaceutical compositions of pimobendan
SG11201504967TA (en) Improved antimicrobial compositions
GB201220354D0 (en) Dermal compositions
HUE051744T2 (hu) Kitozánból származtatott készítmények
GB2511197B (en) Compositions
EP2898515A4 (en) PELABLE SEMICONDUCTOR SHIELDING COMPOSITIONS
EP2832346A4 (en) AQUEOUS DISPERSED COMPOSITION
ZA201406786B (en) Anti-malarial agents
PL2887924T3 (pl) Kompozycje farmaceutyczne etorykoksybu
PL3021840T3 (pl) Kompozycje do zapobiegania reakcji alergicznej
ZA201408094B (en) Anti-malarial agents
PL3398594T3 (pl) Kompozycje do ulepszenia funkcji mózgu
ZA201408945B (en) Stabilized aqueous compositions of neuromuscular blocking agents
GB201201287D0 (en) Compositions
GB201210397D0 (en) Crop enhancement compositions
IL238381B (en) Transdermal preparations based on propyleneaminoindan
IL217807A0 (en) Therapeutic compositions
GB201300064D0 (en) Microparticle compositions
IL239899A0 (en) Preparations of thiazomycin compounds
GB201420685D0 (en) Aqueous disinfectant composition